Corpus Intelligence IC Memo — ARKANSAS SURGICAL HOSPITAL 2026-04-26 04:05 UTC
IC Memo — ARKANSAS SURGICAL HOSPITAL
Investment Committee Memorandum | AR | 47 beds | Grade C | EBITDA uplift $5.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ARKANSAS SURGICAL HOSPITAL

CCN 040147 | PULASKI, AR | 47 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ARKANSAS SURGICAL HOSPITAL is a 47-bed rural/critical access in PULASKI, AR with $75.1M in net patient revenue and a 11.7% operating margin. The hospital serves a payer mix of 55.3% Medicare, 0.1% Medicaid, and 44.6% commercial.

Thesis: Turnaround. Our ML models identify $5.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.7% to 19.0% (+736bps).

Net Revenue HCRIS$75.1M
Current EBITDA COMPUTED$8.8M
Operating Margin COMPUTED11.7%
Occupancy HCRIS28.0%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS28.9%
Distress Probability ML52.6%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
62
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 11.7% places it above the state median. Among 62 size-comparable peers (24-94 beds), the median margin is -12.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-94), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ARKANSAS SURGICAL HOSPITAL (Target)AR47$75.1M11.7%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
SILOAM SPRINGS MEMORIAL HOSPITAR64$85.0M8.4%
ST VINCENT NORTHAR68$72.1M-18.7%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
ENCOMPASS HEALTH REHABILITATIOAR80$36.3M27.9%
DREW MEMORIAL HOSPITAL INCAR49$35.3M-27.2%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.6M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$914K+122bp9mo
Clean Claim Rate88.0%96.0%$48K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.6M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.5M
A/R Days Reduction
$914K
Clean Claim Rate
$48K
Total EBITDA Uplift$5.5M
Current EBITDA$8.8M
+ RCM Uplift+$5.5M
Pro Forma EBITDA$14.3M
Current Margin11.7%
Pro Forma Margin19.0%
WC Released (1x)$2.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$13.5M$113.0M8.39x53.0%
Base (11x exit)10.0x11.0x$13.5M$128.7M9.56x57.1%
Bull Case9.0x11.0x$12.1M$151.3M12.49x65.7%
Bull (12x exit)9.0x12.0x$12.1M$168.7M13.92x69.3%
Bear Case11.0x10.0x$14.8M$81.0M5.47x40.5%
Bear (11x exit)11.0x11.0x$14.8M$93.9M6.34x44.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 55.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 28.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 24-94 beds
  • Same-state prioritization (n=63)
  • Comp margins: P25=-24.2% / P50=-12.4% / P75=5.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.